Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVT vs GSK✓SelectedUSD · GSKNVT vs GSK performance historyLatest closeAs of-5.79%11/20
Stock and ETF performance explorer

NVT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+434.1%
GSK return
+73.8%
Excess return
+360.3%
Maximum drawdown
-56.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.8%-0.1%-5.7%-5.8%
7D-11.2%-5.3%-5.9%-9.9%
30D-30.2%-3.7%-26.5%-29.8%
3M-33.9%-7.3%-26.6%-33.0%
6M-36.9%-4.2%-32.7%-37.3%
YTD+0.5%+0.9%-0.4%-2.6%
1Y+1.0%+7.3%-6.3%-4.6%
3Y+95.5%+52.7%+42.7%+50.6%
5Y+193.2%+40.1%+153.1%+130.6%
All+434.1%+73.8%+360.3%+269.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling